Katherine Olmstead
Family · Philadelphia, PANPI 1699211029
Payments from drug & device makers
Across 84 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$462
- Novo Nordisk$310
- Johnson & Johnson$232
- AstraZeneca$153
- ARS Pharmaceuticals Operations, Inc.$149
- Pfizer$100
- plus $654 from 20 others
What the payments were for
- Food & beverage$2,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $462 |
| Novo Nordisk | 19 | $310 |
| Johnson & Johnson | 2 | $232 |
| AstraZeneca | 4 | $153 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $149 |
| Pfizer | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Astellas Pharma US Inc | 3 | $59 |
| GSK | 3 | $57 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Exeltis, USA Inc. | 2 | $41 |
| Pharmacosmos Therapeutics Inc. | 1 | $34 |
| Corium, LLC | 2 | $34 |
| Exact Sciences | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Eisai Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Millicent US Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,060 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 40 | $672 |
| Fluticasone Propionate | 49 | $589 |
| Azelastine Hcl | 23 | $586 |
| Levothyroxine Sodium | 36 | $499 |
| Olmesartan Medoxomil | 13 | $484 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $418 |
| Tamsulosin Hcl | 14 | $306 |
| Atorvastatin Calcium | 38 | $286 |
| Mupirocin | 24 | $284 |
| Methylprednisolone | 44 | $282 |
| Escitalopram Oxalate | 23 | $281 |
| Cyclobenzaprine Hcl | 21 | $276 |
| Amlodipine Besylate | 42 | $269 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $234 |
| Losartan Potassium | 24 | $205 |
Paid to pharmacies, not to this prescriber.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Anne CalvaresiPhiladelphia$81K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.